Acadia Healthcare (NASDAQ:ACHC) Given New $22.00 Price Target at TD Cowen

Acadia Healthcare (NASDAQ:ACHC) had its price target lowered by TD Cowen from $25.00 to $22.00 in a report issued on Friday,Benzinga reports. TD Cowen currently has a buy rating on the stock.

Several other brokerages have also issued reports on ACHC. Guggenheim decreased their price target on shares of Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a research note on Monday, November 10th. Barclays decreased their target price on Acadia Healthcare from $17.00 to $14.00 and set an “equal weight” rating for the company in a research report on Thursday, December 4th. KeyCorp dropped their price target on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 3rd. UBS Group cut their price target on Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating for the company in a research note on Wednesday, December 3rd. Finally, Bank of America cut Acadia Healthcare from a “neutral” rating to an “underperform” rating and lowered their price objective for the company from $21.50 to $13.00 in a research note on Wednesday, December 3rd. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $18.92.

Acadia Healthcare Stock Down 1.9%

Shares of NASDAQ:ACHC opened at $11.68 on Friday. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $45.61. The company has a market capitalization of $1.08 billion, a PE ratio of 9.98, a price-to-earnings-growth ratio of 3.12 and a beta of 0.88. The business has a fifty day moving average price of $14.77 and a two-hundred day moving average price of $19.98. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.44 and a quick ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. The company had revenue of $851.57 million for the quarter, compared to the consensus estimate of $852.43 million. During the same period in the previous year, the firm earned $0.91 EPS. The firm’s quarterly revenue was up 4.4% on a year-over-year basis. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Analysts forecast that Acadia Healthcare will post 3.38 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of ACHC. Allworth Financial LP boosted its position in shares of Acadia Healthcare by 676.4% in the second quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock valued at $31,000 after acquiring an additional 1,177 shares during the period. EverSource Wealth Advisors LLC lifted its stake in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares in the last quarter. Hantz Financial Services Inc. boosted its holdings in Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after purchasing an additional 1,822 shares during the period. CWM LLC grew its position in shares of Acadia Healthcare by 105.1% during the 2nd quarter. CWM LLC now owns 2,633 shares of the company’s stock valued at $60,000 after purchasing an additional 1,349 shares in the last quarter. Finally, Quent Capital LLC bought a new position in shares of Acadia Healthcare in the third quarter worth $71,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.